Ensign Peak Advisors, Inc
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in PHAT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$18,084,924
-$20,935,087 QoQ
Shares Held
1,627,806
-30.8% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,680 across 116 Biotechnology names. PHAT ranks #23 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in PHAT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,084,924 | 1,627,806 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $39,020,011 | 2,352,020 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,464,358 | 2,503,344 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,166,531 | 2,519,972 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,764,560 | 2,514,284 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,519,678 | 2,527,054 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $46,671,495 | 2,581,388 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,121,728 | 2,244,828 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $24,213,600 | 2,280,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $20,816,400 | 2,280,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $17,962,623 | 1,732,172 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,162,058 | 1,757,127 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,574,903 | 1,761,191 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,760,563 | 1,761,191 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,513,996 | 1,761,191 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,141,118 | 1,675,488 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,035,769 | 1,104,759 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $25,880,153 | 1,315,717 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $37,564,190 | 1,170,224 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $41,297,338 | 1,220,010 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $46,554,192 | 1,239,462 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $40,679,617 | 1,224,552 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $32,738,682 | 892,792 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $27,973,598 | 850,003 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $15,427,243 | 597,492 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||